Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes

Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes

Show other versions (1)

Abstract Background Angiogenin, an enzyme belonging to the ribonucleases A superfamily, plays an important role in vascular biology. Here, we sought to study the association of plasma angiogenin and major adverse cardiovascular events (MACEs) in patients with type 2 diabetes (T2D). Methods This pros...

Full description

Bibliographic Details
Main Authors:	Resham L. Gurung, Sylvia Liu, Jian-Jun Liu, Yiamunaa M., Huili Zheng, Clara Chan, Keven Ang, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim
Format:	Article
Language:	English
Published:	BMC 2024-02-01
Series:	Cardiovascular Diabetology
Subjects:	Angiogenin Major adverse cardiovascular events Type 2 diabetes
Online Access:	https://doi.org/10.1186/s12933-024-02156-8

Similar Items

Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes
by: Gurung, Resham L., et al.
Published: (2024)

Angiogenin and osteopontin and coronary collateral circulation
by: Joob Beuy, et al.
Published: (2019-09-01)

Phospholipid Scramblase 1 Functionally Interacts with Angiogenin and Regulates Angiogenin-Enhanced rRNA Transcription
by: Junqiao Zhu, et al.
Published: (2013-12-01)

Human and mouse angiogenins: Emerging insights and potential opportunities
by: Mst. Farzana Sultana, et al.
Published: (2022-11-01)

The association between serum angiogenin and osteopontin levels and coronary collateral circulation in patients with chronic total occlusion
by: Kadri Murat Gürses, et al.
Published: (2019-08-01)

Functional Recovery and Serum Angiogenin Changes According to Intensity of Rehabilitation Therapy After Stroke
by: Nicolás Garcia-Rodriguez, et al.
Published: (2021-11-01)

Angiogenin in the Neurogenic Subventricular Zone After Stroke
by: Marina Gabriel-Salazar, et al.
Published: (2021-06-01)

HBV Facilitated Hepatocellular Carcinoma Cells Proliferation by Up-Regulating Angiogenin Expression Through IL-6
by: Xiaotang Zhou, et al.
Published: (2018-03-01)

Identification of Crucial Amino Acid Residues for Antimicrobial Activity of Angiogenin 4 and Its Modulation of Gut Microbiota in Mice
by: Mst. Farzana Sultana, et al.
Published: (2022-06-01)

XPS Modeling of Immobilized Recombinant Angiogenin and Apoliprotein A1 on Biodegradable Nanofibers
by: Anton Manakhov, et al.
Published: (2020-05-01)

The Antimicrobial Peptides Human β-Defensins Induce the Secretion of Angiogenin in Human Dermal Fibroblasts
by: Yoshie Umehara, et al.
Published: (2022-08-01)

Correlation of serum angiogenin level with various vascular complications in type 2 diabetic patients
by: Nagwa F. Ahmed, et al.
Published: (2012-01-01)

Angiogenin Levels and Their Association with Cardiometabolic Indices Following Vitamin D Status Correction in Saudi Adults
by: Ghadeer M. Aldawsari, et al.
Published: (2022-02-01)

Identification, tissue characterization, and innate immune role of Angiogenin-4 expression in young broiler chickensa
by: Daniela Losada-Medina, et al.
Published: (2020-06-01)

Prediabetes increases the risk of major limb and cardiovascular events
by: Jung-Chi Hsu, et al.
Published: (2023-12-01)

Excess Risk of Major Adverse Cardiovascular and Kidney Events after Acute Kidney Injury following Living Donor Liver Transplantation
by: Yi-Chia Chan, et al.
Published: (2022-05-01)

Importance of Angiogenin and Endothelial Progenitor Cells After Rehabilitation Both in Ischemic Stroke Patients and in a Mouse Model of Cerebral Ischemia
by: Marina Gabriel-Salazar, et al.
Published: (2018-06-01)

L-mimosine and hypoxia can increase angiogenin production in dental pulp-derived cells
by: Klara Janjić, et al.
Published: (2017-05-01)

Characterization and Function of the Interaction of Angiogenin With Alpha-Actinin 2
by: Chunhua Weng, et al.
Published: (2022-04-01)

Long‐Term Visit‐to‐Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes
by: Jung‐Chi Hsu, et al.
Published: (2023-02-01)

Molecular Mechanisms in Amyotrophic Lateral Sclerosis: The Role of Angiogenin, a Secreted RNase
by: Isabela M. Aparicio-Erriu, et al.
Published: (2012-11-01)

Effects of secukinumab and ixekizumab on major adverse cardiovascular events in patients with psoriasis: a meta-analysis of randomized controlled trials
by: Yonghong Zhang, et al.
Published: (2024-03-01)

Stimulation of mouse hematopoietic stem cells by angiogenin and DNA preparations
by: E.A. Potter, et al.
Published: (2024-03-01)

Effects of angiogenin on granulosa and theca cell function in cattle
by: J.L. Dentis, et al.
Published: (2017-01-01)

Quantification of substoichiometric modification reveals global tsRNA hypomodification, preferences for angiogenin-mediated tRNA cleavage, and idiosyncratic epitranscriptomes of human neuronal cell-lines
by: Florian Pichot, et al.
Published: (2023-01-01)

A computational approach to analyze the missense mutations in human angiogenin variants leading to amyotrophic lateral sclerosis
by: K. Sreevishnupriya, et al.
Published: (2013-11-01)

Dimerization of Human Angiogenin and of Variants Involved in Neurodegenerative Diseases
by: Sabrina Fasoli, et al.
Published: (2021-09-01)

Angiogenin Levels and Carotid Intima-Media Thickness in Patients with Type 1 Diabetes and Metabolic Syndrome
by: Jolanta Neubauer-Geryk, et al.
Published: (2023-09-01)

Angiogenin mutations in Hungarian patients with amyotrophic lateral sclerosis: Clinical, genetic, computational, and functional analyses
by: Kornélia Tripolszki, et al.
Published: (2019-06-01)

Association of NFKB1 gene rs28362491 mutation with the occurrence of major adverse cardiovascular events
by: Jun-Yi Luo, et al.
Published: (2022-07-01)

Comparative efficacy of pharmacological agents on reducing the risk of major adverse cardiovascular events in the hypertriglyceridemia population: a network meta-analysis
by: Yan-yan Qi, et al.
Published: (2021-01-01)

NMR Characterization of Angiogenin Variants and tRNA<sup>Ala</sup> Products Impacting Aberrant Protein Oligomerization
by: Andrea Fagagnini, et al.
Published: (2021-02-01)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
by: Meifan Zheng, et al.
Published: (2020-06-01)

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
by: Michael J. Cutler, et al.
Published: (2022-12-01)

Human Cytolytic Fusion Proteins: Modified Versions of Human Granzyme B and Angiogenin Have the Potential to Replace Bacterial Toxins in Targeted Therapies against CD64+ Diseases
by: Nina Berges, et al.
Published: (2014-02-01)

Preliminary Assessment of Burn Depth by Paper-Based ELISA for the Detection of Angiogenin in Burn Blister Fluid—A Proof of Concept
by: Shin-Chen Pan, et al.
Published: (2020-02-01)

Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study
by: Mihui Kim, et al.
Published: (2022-05-01)

Risk factors for major adverse cardiovascular events after the first acute coronary syndrome
by: Marjo Okkonen, et al.
Published: (2021-01-01)

Predicting Major Adverse Cardiovascular Events Following Carotid Endarterectomy Using Machine Learning
by: Ben Li, et al.
Published: (2023-10-01)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
by: Zhihao Chen, et al.
Published: (2018-11-01)